Recombinant subcutaneous allergy desensitization vaccine (ALK-Abello)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant subcutaneous allergy desensitization vaccine (ALK-Abello)
Drug Alias NamePharmalgen
ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsHypersensitivity
Approved Indications in ChinaN/A
Original Approved Country/TerritorySwitzerland
Original Approved Date1981/03/01
Country/TerritoryNetherlandsSwitzerlandUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAlk-Abello Sa
China Registration ClassN/A

Develop Information

Active CompaniesAlk-Abello Sa
Inactive CompaniesN/A
Active IndicationsHypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeV01AA
Related LinksN/A